Novavax traded just 36 Cents last May! hoping to revive its shares and remain compliant with the NASDAQ Market rules, the Maryland company did exactly what penny stock companies do, Novavax did a 1-for-20 reverse stock split but still finished the year 2019 down another 39%! The Vaccine stock skyrocketed after the government funding announcement rewarding a Big Bet. The Corona Virus changed Novavax’s future and delivered a huge windfall for a backer! The federal government awarded the money to support the development of a potential vaccine. Novavax said it would use the funding for clinical trails for its experimental vaccine and build manufacturing facility to produce vaccine if the company gets FDA approval.
How to expedite your most promising Covid-19, Corona Virus, Monkey Pox drugs, therapies and cures
Our unique platform, deep understanding of OTC Market & Penny Stocks and the ability to provide comprehensive one-stop IR/PR solution makes us the partner of choice for companies that are looking to access funding made available by the Federal Government. Dozens of companies from small startups to Astra Zeneca have already received billions of dollars in ‘grants’, forgivable loans, funding for testing, conducting clinical trials, equipment and manufacturing facility loans. If you want to ensure that you get the funding you need to advance your COVID-19 drug development program, you need to act now!
The Covid Vaccine Most Likely to be Approved First Racing to Ramp- Up Production. Those who bought just a thousand Shares of this stock made $30,000 in 15 Days
BioNTech, a company founded by Dr. Sahin and his wife Özlem Türeci, earlier this year developed over 20 vaccine candidates based on the novel mRNA technology that seeks to program the body to create a protein that would help it combat the coronavirus.
In March, the company teamed up with Pfizer, building on an earlier partnership to jointly develop an mRNA-based influenza vaccine. In July, the companies began the late-stage trial of the candidate that it deemed most promising.
BioNTech and Pfizer are among a handful of companies in advanced stages of testing their vaccine. They committed to supplying over 450 million doses this year and next year, contingent on late-stage trials showing the vaccine to be safe and effective, and governments give the go-ahead for its use.
The U.S. government placed an initial order of 100 million doses, with the option to purchase 500 million additional doses. The EU ordered 200 million doses with an option for another 100 million. The government of Japan ordered 120 million doses, and Britain ordered 30 million.All orders are subject to regulatory approval, and only the price of the U.S. deal—$1.95 billion—has been disclosed so far. Learn more about this huge money maker click here
The CEO Platform!
Rapidly Growing Emerging Companies use CEO Platform to Accelerate Growth. Our Platform provides essential investor acquisition tools and retention solutions for CEOs, so they can grow their companies quickly and easily. Stop wasting your valuable time on the mundane, less lucrative IR/PR tasks. You focus on what most matters to you: Taking Your Company to The Next Level. Let our team of specialists take care of the critical task of increasing your investor base and funding resources for you.